NursesPrint Go Premium
HESI LPN Pharmacology

HESI LPN

HESI LPN Pharmacology

Difficulty: Medium Average Score: 94% Practice

A 52-year-old postmenopausal patient has evidence of low bone mineral density. She and her physician are considering therapy with raloxifene or a combination of conjugated estrogens and medroxyprogesterone acetate. Which of the following patient characteristics is most likely to lead them to select raloxifene?

Related Questions

View all